Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity

Bibliography

• Heikkila AM. Antibiotics in pregnancy – a prospective cohort study on the policy of antibiotic prescription. Ann Med 1993;25(5):467-71
   PubMed Web of Science ®Google Scholar
• de Jonge L, Bos HJ, van Langen IM, et al. Antibiotics. prescribed before, during and after pregnancy in the Netherlands: a drug utilization study. Pharmacoepidemiol Drug Saf 2014;23(1):60-8
   PubMed Web of Science ®Google Scholar
• Santos F, Oraichi D, Berard A. Prevalence and predictors of anti-infective use during pregnancy. Pharmacoepidemiol Drug Saf 2010;19(4):418-27
   PubMed Web of Science ®Google Scholar
• Broe AP, Pottegård A, Lamont R, et al. The increasing use of antibiotics in pregnancy from 2000-2010: prevalence, timing, category and demographics. BJOG 2014;121(8):988-96
   PubMed Web of Science ®Google Scholar
• Guinto VT, De Guia B, Festin MR, Dowswell T. Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. Cochrane Database of Syst Rev 2010(9):CD007855
   Google Scholar
• Vazquez Juan C, Abalos E. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev 2011(1):CD002256
   Google Scholar
• Cooper WO, Ray WA, Griffin MR. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol 2002;100(1):101-6
   PubMed Web of Science ®Google Scholar
• Vlastarakos PV, Manolopoulos L, Ferekidis E, et al. Treating common problems of the nose and throat in pregnancy: what is safe? Eur Arch Otorhinolaryngol 2008;265(5):499-508
   PubMed Web of Science ®Google Scholar
• Mirkin BL. Perinatal pharmacology: placental transfer, fetal localization, and neonatal disposition of drugs. Anesthesiology 1975;43(2):156-70
   PubMed Web of Science ®Google Scholar
• Money DM. Antiviral and antiretroviral use in pregnancy. Obstetr Gynecol Clin North Am 2003;30(4):731-49
   PubMed Web of Science ®Google Scholar
• Romoren M, Lindbaek M, Nordeng H. Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. Br J Clin Pharmacol 2012;74(6):1053-62
   PubMed Web of Science ®Google Scholar
• Crider KS, Cleves MA, Reefhuis J, et al. Antibacterial medication use during pregnancy and risk of birth defects: national Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009;163(11):978-85
   PubMed Web of Science ®Google Scholar
• FDA. United States FDA pharmaceutical pregnancy categories. Fed Regist 1980;44:37434-67
   Google Scholar
• Lynch JP, Clark NM, Zhanel GG. Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum B-lactamases and carbapenemases). Expert Opin Pharmacother 2013;14(2):199-210
   PubMed Web of Science ®Google Scholar
• El Salabi A, Walsh TR, Chouchani C. Extended spectrum beta-lactamases, carbapenamases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria. Crit Rev Microbiol 2013;39(2):113-22
   PubMed Web of Science ®Google Scholar
• Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17(10):1791-8
   PubMed Web of Science ®Google Scholar
• Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gram-negative bacteria. Annu Rev Microbiol 2011;65:455-78
   PubMed Web of Science ®Google Scholar
• Christensen B. Which antibiotics are appropriate for treating bacteriuria in pregnancy? J Antimicrob Chemother 2000;46(Suppl 1):29-34; discussion 63-5
   Google Scholar
• Mylonas I. Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet 2011;283(1):7-18
   PubMed Web of Science ®Google Scholar
• Lamp KC, Freeman CD, Klutman NE, Lacy MK. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet 1999;36(5):353-73
   PubMed Web of Science ®Google Scholar
• Lamont RF, Sobel JD, Kusanovic JP, et al. Current debate on the use of antibiotic prophylaxis for caesarean section. BJOG 2011;118(2):193-201
   PubMed Web of Science ®Google Scholar
• Strachan DP, Wong HJ, Spector TD. Concordance and interrelationship of atopic diseases and markers of allergic sensitization among adult female twins. J Allergy Clin Immunol 2001;108(6):901-7
   PubMed Web of Science ®Google Scholar
• Tsakok T, McKeever TM, Yeo L, Flohr C. Does early life exposure to antibiotics increase the risk of eczema? A systematic review. Br J Dermatol 2013;169(5):983-91
   PubMed Web of Science ®Google Scholar
• Thomas M, Price D. Prenatal antibiotic exposure and subsequent atopy. Am J Respir Crit Care Med 2003;167(11):1578
   PubMedGoogle Scholar
• McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med 2002;166(6):827-32
   PubMed Web of Science ®Google Scholar
• Murk W, Risnes KR, Bracken MB. Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. Pediatrics 2011;127(6):1125-38
   PubMed Web of Science ®Google Scholar
• Jedrychowski W, Gałaś A, Whyatt R, Perera F. The prenatal use of antibiotics and the development of allergic disease in one year old infants. A preliminary study. Int J Occup Med Environ Health 2006;19(1):70-6
   PubMedGoogle Scholar
• Sariachvili M, Droste J, Dom S, et al. Is breast feeding a risk factor for eczema during the first year of life? Pediatr Allergy Immunol 2007;18(5):410-17
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Halkjaer LB, Hinge R, et al. Risk analysis of early childhood eczema. J Allergy Clin Immunol 2009;123(6):1355-60. e5
   PubMed Web of Science ®Google Scholar
• Stensballe LG, Simonsen J, Jensen SM, et al. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr 2013;162(4):832-8. e3
   PubMed Web of Science ®Google Scholar
• Einarson A, Shuhaiber S, Koren G. Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs 2001;3(11):803-16
   PubMedGoogle Scholar
• Organisation WHO. Congenital abnormalities. [Fact Sheet]. 2014. Available from: www.who.int/mediacentre/factsheets/fs370/en/ [Last accessed 26 May 2014]
   Google Scholar
• Schafer C, Spielmann H, Vetter K. Arzneimittelverordnung in Schwangerschaft und Stillzeit. Elsevier Urbam und Fischer, PA, USA; 2001
   Google Scholar
• Zip C. A practical guide to dermatological drug use in pregnancy. Skin Therapy Lett 2006;11(4):1-4
   Google Scholar
• Czeizel AE, Rockenbauer M, Sorensen HT, et al. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case-control study. Am J Obstetr Gynecol 2001;184(6):1289-96
   PubMed Web of Science ®Google Scholar
• Berkovitch M, Segal-Socher I, Greenberg R, et al. First trimester exposure to cefuroxime: a prospective cohort study. Br J Clin Pharmacol 2000;50(2):161-5
   PubMed Web of Science ®Google Scholar
• Briggs GF, Freeman RK, Yaffe SL. Drugs in pregnancy and lactation. 9th edition. Lippincott Williams & Wilkins, Philadelphia, PA, USA; 2011
   Google Scholar
• Bar-Oz B, Weber-Schoendorfer C, Berlin M, et al. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study. Drug Saf 2012;35(7):589-98
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. Reprod Toxicol 1999;13(6):531-6
   PubMed Web of Science ®Google Scholar
• Bahat Dinur A, Koren G, Matok I, et al. Fetal safety of macrolides. Antimicrob Agents Chemother 2013;57(7):3307-11
   PubMed Web of Science ®Google Scholar
• Brocklehurst P, Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev 2000(1):CD000054
   Google Scholar
• Drinkard CR, Shatin D, Clouse J. Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations. Pharmacoepidemiol Drug Saf 2000;9(7):549-56
   PubMed Web of Science ®Google Scholar
• Kallen BA, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol 2005;20(2):209-14
   PubMed Web of Science ®Google Scholar
• Lin KJ, Mitchell AA, Yau WP, et al. Safety of macrolides during pregnancy. Am J Obstetr Gynecol 2013;208(3):221.e1-8
   PubMedGoogle Scholar
• Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol 2009;23(1):18-28
   PubMed Web of Science ®Google Scholar
• Sarkar M, Woodland C, Koren G, Einarson AR. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006;6:18
   PubMedGoogle Scholar
• Einarson A, Phillips E, Mawji F, et al. A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol 1998;15(9):523-5
   PubMed Web of Science ®Google Scholar
• Andersen JT, Petersen M, Jimenez-Solem E, et al. Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. PLoS One 2013;8(1):e53327
   PubMedGoogle Scholar
• Witt A, Sommer EM, Cichna M, et al. Placental passage of clarithromycin surpasses other macrolide antibiotics. Am J Obstet Gynecol 2003;188(3):816-19
   PubMed Web of Science ®Google Scholar
• Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59(RR-12):1-110
   PubMed Web of Science ®Google Scholar
• Amann U, Egen-Lappe V, Strunz-Lehner C, Hasford J. Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population. Pharmacoepidemiol Drug Saf 2006;15(5):327-37
   PubMed Web of Science ®Google Scholar
• Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003;361(9362):983-8
   PubMed Web of Science ®Google Scholar
• Viniker DA. Hypothesis on the role of sub-clinical bacteria of the endometrium (bacteria endometrialis) in gynaecological and obstetric enigmas. Hum Reprod Update 1999;5(4):373-85
   PubMed Web of Science ®Google Scholar
• Allsworth JE, Peipert JF. Prevalence of Bacterial Vaginosis: 2001-2004 National Health and Nutrition Examination Survey Data. Obstetr Gynecol 2007;109(1):114-20
   PubMed Web of Science ®Google Scholar
• Hay PE, Lamont RF, Taylor-Robinson D, et al. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308(6924):295-8
   PubMed Web of Science ®Google Scholar
• Kurki T, Sivonen A, Renkonen OV, et al. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80(2):173-7
   PubMed Web of Science ®Google Scholar
• Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 2011;118(5):533-49
   PubMed Web of Science ®Google Scholar
• Lamont RF, Nhan-Chang CL, Sobel JD, et al. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol 2011;205(3):177-90
   PubMed Web of Science ®Google Scholar
• Barker RH. The placental transfer of sulfanilamide. N Engl J Med 1938;219(2):41
   Google Scholar
• Eric M, Sabo A. Teratogenicity of antibacterial agents. Coll Antropol 2008;32(3):919-25
   PubMed Web of Science ®Google Scholar
• Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 2003;20(8):405-14
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Puhó E, Sørensen HT, Olsen J. Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy. Congenit Anom 2004;44(2):79-86
   PubMedGoogle Scholar
• Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343(22):1608-14
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001;153(10):961-8
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 494: sulfonamides, nitrofurantoin, and risk of birth defects. Obstet Gynecol 2011;117(6):1484-5
   PubMedGoogle Scholar
• Andersen JT, Petersen M, Jimenez-Solem E, et al. Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study. Epidemiol Infect 2013;141(8):1749-55
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 2001;15(6):637-46
   PubMed Web of Science ®Google Scholar
• Matok I, Gorodischer R, Koren G, et al. Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations. Br J Clin Pharmacol 2009;68(6):956-62
   PubMed Web of Science ®Google Scholar
• Sivojelezova A, Einarson A, Shuhaiber S, et al. Trimethoprim-sulfonamide combination therapy in early pregnancy. Can Fam Physician 2003;49:1085-6
   PubMed Web of Science ®Google Scholar
• Eliopoulos GM, Huovinen P. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis 2001;32(11):1608-14
   PubMed Web of Science ®Google Scholar
• Lucas MJ, Cunningham FG. Urinary infection in pregnancy. Clin Obstet Gynecol 1993;36(4):855-68
   PubMed Web of Science ®Google Scholar
• Nordeng H, Lupattelli A, Romøren M, Koren G. Neonatal outcomes after gestational exposure to nitrofurantoin. Obstet Gynecol 2013;121(2 Pt 1):306-13
   PubMed Web of Science ®Google Scholar
• Goldberg O, Koren G, Landau D, et al. Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations. J Clin Pharmacol 2013;53(9):991-5
   PubMed Web of Science ®Google Scholar
• Paton JH, Reeves DS. Clinical features and management of adverse effects of quinolone antibacterials. Drug Saf 1991;6:8-27
   PubMed Web of Science ®Google Scholar
• Loebstein R, Addis A, Ho E, et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998;42(6):1336-9
   PubMed Web of Science ®Google Scholar
• Berkovitch M, Pastuszak A, Gazarian M, et al. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994;84(4):535-8
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Moretti ME, Boskovic R, et al. The safety of quinolones – a meta-analysis of pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2009;143(2):75-8
   PubMed Web of Science ®Google Scholar
• Schaefer C, Amoura-Elefant E, Vial T, et al. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur J Obstet Gynecol Reprod Biol 1996;69(2):83-9
   PubMed Web of Science ®Google Scholar
• Nishimura H, Tanimura T. Clinical aspects of the teratogenicity of drugs 1976. Excerpta Medica, Amsterdam, Netherlands; 1976
   Google Scholar
• Ward K, Theiler RN. Once-daily dosing of gentamicin in obstetrics and gynecology. Clin Obstetr Gynecol 2008;51(3):498-506
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstetr Gynecol 1997;89(4):524-8
   PubMed Web of Science ®Google Scholar
• Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. Drugs 2013;73(8):779-87
   PubMed Web of Science ®Google Scholar
• Thapa PB, Whitlock JA, Brockman Worrell KG, et al. Prenatal exposure to metronidazole and risk of childhood cancer: a retrospective cohort study of children younger than 5 years. Cancer 1998;83(7):1461-8
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998;105(3):322-7
   PubMedGoogle Scholar
• Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993;82(3):348-52
   PubMed Web of Science ®Google Scholar
• Burtin P, Taddio A, Ariburnu O, et al. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995;172(2 Pt 1):525-9
   PubMed Web of Science ®Google Scholar
• Diav-Citrin O, Shechtman S, Gotteiner T, et al. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 2001;63(5):186-92
   PubMedGoogle Scholar
• Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstetr Gynecol 2006;107(5):1120-38
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. A population-based case-control teratologic study of oral chloramphenicol treatment during pregnancy. Eur J Epidemiol 2000;16(4):323-7
   PubMed Web of Science ®Google Scholar
• Borgia G, Carleo MA, Gaeta GB, Gentile I. Hepatitis B in pregnancy. World J Gastroenterol 2012;18(34):4677-83
   PubMed Web of Science ®Google Scholar
• Andrews WW, Kimberlin DF, Whitley R, et al. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol 2006;194(3):774-81
   PubMed Web of Science ®Google Scholar
• Kang SH, Chua-Gocheco A, Bozzo P, Einarson A. Safety of antiviral medication for the treatment of herpes during pregnancy. Can Fam Physician 2011;57(4):427-8
   PubMed Web of Science ®Google Scholar
• Smith CK, Arvin AM. Varicella in the fetus and newborn. Semin Fetal Neonatal Med 2009;14(4):209-17
   PubMed Web of Science ®Google Scholar
• CDC. Pregnancy outcomes following systemic prenatal acyclovir exposure – June 1, 1984-June 30, 1993. MMWR Morb Mortal Wkly Rep 1993;42(41):806-9
   PubMedGoogle Scholar
• Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst Rev 2008(1):CD004946
   PubMed Web of Science ®Google Scholar
• Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010;304(8):859-66
   PubMed Web of Science ®Google Scholar
• Coll O, Benoist G, Ville Y, et al. Guidelines on CMV congenital infection. J Perinat Med 2009;37(5):433-45
   PubMed Web of Science ®Google Scholar
• Benoist G, Leruez-Ville M, Magny JF, et al. Management of pregnancies with confirmed cytomegalovirus fetal infection. Fetal Diagn Ther 2013;33(4):203-14
   PubMed Web of Science ®Google Scholar
• Jacquemard F, Yamamoto M, Costa JM, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007;114(9):1113-21
   PubMed Web of Science ®Google Scholar
• But DY, Yuen MF, Fung J, Lai CL. Safety evaluation of telbivudine. Expert Opin Drug Saf 2010;9(5):821-9
   PubMed Web of Science ®Google Scholar
• Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011;55(6):1215-21
   PubMed Web of Science ®Google Scholar
• Rosa F. Amantadine pregnancy experience. Reprod Toxicol 1994;8(6):531
   PubMed Web of Science ®Google Scholar
• Linder N, Amarilla M, Hernandez A, et al. Association of high-dose bifonazole administration during early pregnancy and severe limb reduction defects in the newborn. Birth Defects Res A Clin Mol Teratol 2010;88(3):201-4
   PubMed Web of Science ®Google Scholar
• Sobel JD. Use of antifungal drugs in pregnancy: a focus on safety. Drug Saf 2000;23(1):77-85
   PubMed Web of Science ®Google Scholar
• Monif GR, Carson HJ. Female genital tract bacterial coisolates with Candida albicans in patients without clinical vaginitis. Infect Dis Obstet Gynecol 1998;6(2):52-6
   PubMedGoogle Scholar
• Midgley G, Moore MK, Cook JC, Phan QG. Mycology of nail disorders. J Am Acad Dermatol 1994;31(3 Pt 2):S68-74
   Google Scholar
• Jick SS. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy 1999;19(2):221-2
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Moretti ME, Bishai R, et al. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol 2000;183(3):617-20
   PubMed Web of Science ®Google Scholar
• Molgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med 2013;369(9):830-9
   PubMed Web of Science ®Google Scholar
• Norgaard M, Pedersen L, Gislum M, et al. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother 2008;62(1):172-6
   PubMed Web of Science ®Google Scholar
• Chow AW, Jewesson PJ. Use and safety of antimicrobial agents during pregnancy. West J Med 1987;146(6):761-4
   PubMedGoogle Scholar
• Czeizel AE, Métneki J, Kazy Z, Puho E. A population-based case-control study of oral griseofulvin treatment during pregnancy. Acta Obstet Gynecol Scand 2004;83(9):827-31
   PubMed Web of Science ®Google Scholar
• King CT, Rogers PD, Cleary JD, Chapman SW. Antifungal therapy during pregnancy. Clin Infect Dis 1998;27(5):1151-60
   PubMed Web of Science ®Google Scholar
• The Pew Charitable Trust. GAIN: how a new law is stimulating the development of antibiotics. 2013. Available from: www.pewhealth.org/other-resource/gain-how-a-new-law-is-stimulating-the-development-of-antibiotics-85899518481#sthash.mPWCEg9C.dpuf [Last accessed 26 May 14]
   Google Scholar
• Dubakiene R, Rudzeviciene O, Butiene I, et al. Studies on early allergic sensitization in the Lithuanian birth cohort. ScientificWorldJournal 2012;2012:909524
   PubMedGoogle Scholar
• Dom S, Droste JH, Sariachvili MA, et al. Pre- and post-natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years. Clin Exp Allergy 2010;40(9):1378-87
   PubMed Web of Science ®Google Scholar
• Martel MJ, Rey E, Malo JL, et al. Determinants of the incidence of childhood asthma: a two-stage case-control study. Am J Epidemiol 2009;169(2):195-205
   PubMed Web of Science ®Google Scholar
• Rusconi F, Galassi C, Forastiere F, et al. Maternal complications and procedures in pregnancy and at birth and wheezing phenotypes in children. Am J Respir Crit Care Med 2007;175(1):16-21
   PubMed Web of Science ®Google Scholar